Argus analyst David Toung upgraded Silk Road Medical to Buy from Hold with a $24 price target.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SILK:
- Silk Road Medical expands TCAR portfolio with launch of tapered ENROUTE system
- Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System
- Silk Road Medical price target raised to $23 from $20 at Stifel
- Silk Road Medical price target raised to $28 from $20 at Lake Street
- Silk Road Medical price target raised to $18 from $11 at Piper Sandler
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue